You are here: Industry Insights > oncology

News List

GSK adds to cancer offering with $5.1bn Tesaro buy pharmatimes
December 04, 2018
GlaxoSmithKline is buying US oncology biopharma Tesaro for $5.1 billion, marking the first major purchase by the firm since chief executive Emma Walmsley took charge last year.
Blockchain firm Witty Health launches digital cancer decision tool pharmaphorum
November 30, 2018
The health blockchain technology firm Witty Health has launched OncoPower, a digital tool helping oncologists with their decision making.
C4X Discovery launches drug discovery partnership with LifeArc pharmaceutical-technology
November 29, 2018
C4X Discovery has formed a discovery partnership with British medical research charity LifeArc to collaborate on the development of small molecule drug candidates active against a novel oncology and inflammation target......
Alvotech teams with Fuji Pharma for biosimilar portfolio in Japan pharmaceutical
November 21, 2018
Alvotech’s products are used in advanced therapies such as oncology, and autoimmune disease. Credit: Alvotech.
Aurobindo Pharma to launch oncology, respiratory products in US by 2021 expressbpd
November 19, 2018
For the long term, from 2022 onwards, Aurobind Pharma plans “launch of inhalers, transdermals, biosimilars, and branded (both Rx and OTC) products in advanced markets,” the presentation said.
F1 Oncology Expands Operations contractpharma
November 19, 2018
F1 Oncology, a biotechnology company discovering and developing adoptive cellular therapies (ACTs) for solid tumors, sai
Oncology Analytics raises $21M Series B financing led by Oak HC/FT biospectrumasia
November 07, 2018
Prominent healthcare investor Oak HC/FT joined by McKesson Ventures, Blue Cross Blue Shield Venture Partners and Sandbox Advantage Fund to Accelerate Patient-First Oncology Benefits Management
Discovery of cancer ‘kill code’ could inspire new treatments fiercebiotech
November 02, 2018
Scientists at Northwestern University have discovered a “kill code” in every cell of the body that’s triggered by chemotherapy and that causes cancerous cells to self-destruct. What’s more, they’...
GlaxoSmithKline mulls respiratory exit to support big bet on cancer R&D fiercebiotech
November 02, 2018
GlaxoSmithKline may exit the respiratory business and pull back in other areas to commit more cash to cancer R&D, according to Axel Hoos. Hoos, GSK’s head of oncology, ...
Curadev, Endo Pharma oncology program reaches milestone biospectrumasia
October 29, 2018
Curadev, Endo Pharma oncology program reaches milestone

Previous page 1 2 3 4 5 6 7 8 9 10 ... 18 19 Next page